Biomedilam in Châteaubriant: a key player in medical innovation by 2025
In the heart of the Châteaubriant region, Biomedilam is establishing itself as a key player in medical innovation by 2025. Integrated into a dynamic ecosystem, the laboratory combines technological expertise with local presence, supporting the digital transformation and continuous improvement of healthcare in Loire-Atlantique.
Biomedilam, a driving force in medical testing in Châteaubriant by 2025
- With a strong presence in Châteaubriant, Biomedilam has become a leading regional medical testing laboratory. Thanks to its modern infrastructure and a network of nine complementary facilities, this laboratory provides services covering all biological specialties while continuously innovating its processes.
- 🔬 Nearly 400 tests performed per day, demonstrating significant operational capacity
- 📈 Gradual integration of artificial intelligence tools to optimize sample detection and analysis
| 💻 Adoption of a 100% digital solution, facilitating the rapid and secure transmission of results | ⚙️ Close collaboration with major industry players such as Sanofi, BioMérieux, and Thermo Fisher Scientific France | Criterion 🧪 | Before 2025 |
|---|---|---|---|
| 2025 Outlook | Local Impact 🌍 | Testing Capacity | 200 tests/day |
| 400 tests/day | Rapid response to the growing demand from the CC Châteaubriant-Derval inter-municipal community | Digitization | Partial |
| Fully digital processes | Improved traceability and reduced turnaround times | Industrial Partnerships | Limited |
Collaboration with Astellas Pharma France, LFB, Biosynex, and Dassault Systèmes (Medidata) Sustained innovation and increased responsiveness to local medical needs This ongoing development was detailed in a recent interview in Ouest Franceand analyzed on
Xerfi
.
- Innovative technologies and strategic collaborations strengthening healthcare in Loire-Atlantique
- Biomedilam, through its alliance with renowned pharmaceutical and technology groups, is embracing digitalization and robotics to optimize diagnosis and medical care.
- 🤖 Deployment of robotic tools and artificial intelligence in sample analysis
| 🧬 Partnership with Sanofi and bioMérieux for research and development of new techniques | 💉 Collaboration with Guerbet and Servier for the development of innovative pharmaceutical solutions | 📊 Integration of Medidata by Dassault Systèmes for advanced clinical data management | Partner 💼 |
|---|---|---|---|
| Area of collaboration | Key contribution | Impact for Châteaubriant and the region | Sanofi |
| Pharmaceutical | Innovation in vaccines and treatments | Facilitated access to innovative treatments for the local population | BioMérieux |
| Molecular diagnostics | Rapid microbial identification technologies | Faster diagnosis, effective infection prevention | Thermo Fisher Scientific France |
Medical instrumentation Provision of cutting-edge equipment Laboratory capacity upgrade with high-performance equipment Recent projects highlight this collaborative dynamic, in particular onActu.fr
LinkedIn Biomedilam
- https://www.youtube.com/watch?v=Ii0MnvKgig8
- Biomedilam’s Impact on Health and the Local Economy of the Pays de la Mée and Loire-Atlantique Region
- Beyond its role in the healthcare sector, Biomedilam acts as a key economic driver in the Châteaubriant region. Its investments in medical technologies promote employment and boost the region’s attractiveness.
color: #444;
showDetail(); div.focus(); } });
}
// Initialization: inserts all items and focuses on the first one
data.items.forEach((item, i) => {
const el = createItem(item, i);
container.appendChild(el);
});
/ By default, display the first item in detail
if(data.items.length > 0) {